Clin2
NCT07511933Possibly a fitRecruiting

New PET scan to detect tumor regrowth vs. scar tissue in brain

Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Brain Metastases From MelanomaBrain Metastases From Breast Cancer

Part of Brain & nervous system, Cancer clinical trials.

This study tests a new type of PET scan (a special imaging test) that uses a radioactive tracer to help doctors tell the difference between scar tissue from past radiation and cancer that has come back in the brain. This could help avoid unnecessary surgery or additional treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
Any age
Study type
Interventional

Who can take part

  • You are 18 years old or older
  • You have cancer that has spread to the brain (lung, melanoma, or breast cancer), OR you had brain metastases treated with radiation at least 9 months ago, OR doctors are unsure if a brain lesion is scar tissue or recurrent cancer
  • You have a measurable brain lesion at least 10mm in size
  • You are in good enough health to tolerate the scan (WHO performance status 0–3)
  • You are not pregnant and have no known allergy to the Ga68-PSMA tracer
  • You have not had a seizure in the last 7 days and your life expectancy is at least 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06444412Recruiting· Phase 2
Testing a new PET scan to detect brain tumor recurrence

This trial tests a special imaging scan called Ga-68 PSMA-11 PET/CT to see if it can better detect when a glioma brain tumor has come back or progressed. It is for people who have already had standard treatment and are planning surgery for a suspected recurrence.

Rochester, Minnesota
NCT05452005Recruiting· Phase 1
PET scan with a new tracer for lung cancer brain metastases

This Phase 1 study tests whether a specialized PET scan tracer can “light up” metastatic non-small cell lung cancer in the brain. If you join, you’ll get brain MRI and PET/CT scans and you’ll continue with your planned cancer treatments and follow-up imaging.

Sacramento, California
NCT06696326Recruiting
New PET scan for prostate cancer detection

This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.

Xiamen, Fujian
NCT06560905Recruiting· Phase 2
PSMA-PET scan before melanoma surgery

This trial tests if a special scan (PSMA-PET) can help plan surgery for melanoma that has spread to lymph nodes. It may help doctors remove all cancer more accurately.

London
NCT06835244Enrolling by invitation
Study of PSMA PET/CT scans for non-prostate cancers

This study looks at how well a special scan (PSMA PET/CT) works for people with cancers other than prostate cancer. If your doctor already scheduled this scan for your care, you may be able to help researchers learn more about its accuracy.

Bologna
NCT07649122Recruiting· Phase 3
PET Scan Imaging for Prostate Cancer Recurrence Detection

This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.

Nanjing, Jiangsu

Hear when a new Brain Metastases From Non-small Cell Lung Cancer (NSCLC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.